CEBPA Gene Sequencing

Definition

Biallelic (double allele) mutations in the CEBPA gene are found in 2 to 15% of de novo AML patients and are defined as a separate disease entity in the WHO classification. Unlike single-allele mutations, biallelic mutations (especially those in the bZIP region) are significantly associated with better event-free and overall survival.

Gene/Region Examined

CEBPA Exon 1

Method

DNA analysis

Accepted Sample Types

Fresh tumor tissue, FFPE

Inheritance

Mostly somatic, but in rare familial AML syndromes a germline mutation may be found in one allele of CEBPA; in these cases a somatic mutation is later added to the second allele, making it biallelic.

Related Tests